Diabetes Mellitus (DM) is a metabolic disease defined by hyperglycaemia due to defects in insulin secretion, insulin action, or both. The predominance of diabetes has increased worldwide in both genders equally . There is a dramatic increase in the ubiquity of diabetes owing to modernization and urbanization that has brought about a substantial burden on the health care services. Metabolic syndrome (Met S) is defined as a cluster of cardiovascular risk factors which include raised fasting plasma glucose, central obesity, and hypertension, raised triglycerides, and reduced HDL cholesterol . Also known as syndrome X or insulin resistance syndrome, it has been recognized since 1980s. The guidelines for the diagnosis of metabolic syndrome have been given by different organizations such as World Health Organization (WHO), International Diabetic Federation (IDF), and National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) imparted a new working definition of the metabolic syndrome and thus, it is easily applicable and provides strong clinical evidence. The MetS is influenced by several factors, some of which can accelerate the disease’s progression to various complications that aggravate the morbidity.

DM is associated with a three to five fold increased risk for the development of Metabolic Syndrome (Met S) which has now reached high proportions in many countries. MetS is known to be caused by insulin resistance or insulin resistance-linked obesity, a condition whereby the body’s cells are incapable of taking up glucose from the blood. Insulin resistance-linked obesity is caused by poor dieting and lack of regular exercise. Other genetic or lifestyle risk factors equally lead to the metabolic Met S. This leads to the development of macro and micro vascular complications in patients with Diabetes Mellitus. There is little information on MetS causes and predictor factors, due to few published data on the prevalence of Met S and its association with type II diabetes mellitus. There are difference in the prevalence of metabolic syndrome in different ethnic population due to difference in lifestyle, distribution of different risk factors, knowledge and awareness about metabolic diseases. The primary objective of the study is to identify the occurrence of Metabolic Syndrome (Met S) among type II DM patients. Secondary objective is to assess the gender related difference in risk factors associated with metabolic syndrome. The proposed study will help to identify the occurrence of metabolic syndrome among DM population and will help to understand the association between each components of metabolic syndrome with gender. Identification of MetS in patients with DM will be useful in predicting other complications and it will help to devise more targeted interventions.